Home Newsfeeds CJS Securities Upgrades Vicor to Market Outperform

CJS Securities Upgrades Vicor to Market Outperform

CJS Securities analyst Jonathan Tanwanteng upgrades Vicor (NASDAQ:VICR) from Market Perform to Market Outperform.

byBenzinga Newsdesk

October 26, 2022

1 minute read

CJS Securities analyst Jonathan Tanwanteng upgrades Vicor (NASDAQ:VICR) from Market Perform to Market Outperform.

News

ŌURA and Talkspace Launch First-Of-Its-Kind Holistic Sleep Partnership

By Happy Mohamed

August 30, 10:43 AM

Powered by leading smart ring's new Share Report feature to provide insights for more personalized care Today ŌURA, the company behind the smart ring that delivers personalized health data, insights, and

TALK

Why Apple Stock Is Losing Flavor Premarket Today

By Shanthi Rexaline

August 4, 5:08 AM

Apple shares pulled back in premarket after investors expressed uneasiness over a miss for most product categories in Q3 and its lackluster guidance.

AAPL

NVIDIA, Johnson & Johnson And 2 Other Stocks Insiders Are Selling

By Lisa Levin

June 15, 8:21 AM

The S&P 500 closed slightly higher on Wednesday. Investors, meanwhile, focused on some notable insider trades.

HOOD

Reported April 19, Bright Minds Biosciences Receives A Favorable Written Opinion From The International Searching Authority For BMB-202

By Benzinga Newsdesk

April 20, 12:44 AM

-- BMB-202 is a highly selective 5-HT2A agonist that exhibits a more than 30-fold selectivity over 5-HT2C and more than 500-fold selectivity over 5-HT2B -- -- BMB-202 is the first clinical candidate from an

CSE:DRUG

CJS Securities Upgrades Vicor to Market Outperform

Related Posts

ŌURA and Talkspace Launch First-Of-Its-Kind Holistic Sleep Partnership

Why Apple Stock Is Losing Flavor Premarket Today

NVIDIA, Johnson & Johnson And 2 Other Stocks Insiders Are Selling

Reported April 19, Bright Minds Biosciences Receives A Favorable Written Opinion From The International Searching Authority For BMB-202